how will evolving future therapies change how we position biologics for use in ibd
Published 9 years ago • 354 plays • Length 16:46Download video MP4
Download video MP3
Similar videos
-
21:02
should we change how we position biologics for use in crohn’s disease?
-
22:55
should we change how we position biologics for use in ulcerative colitis?
-
21:25
how will new and future therapies change our treatment of ibd?
-
44:08
the evolution of personalized ibd care: navigating mechanisms of biologic therapies
-
21:36
how will future therapeutic pathways change for ulcerative colitis and crohn's disease?
-
21:14
when and how to use immunomodulators and biologics in ibd
-
49:17
the evolving therapeutic paradigm in ibd: optimal positioning of new and emerging agents
-
28:12
current and evolving therapeutic landscape of ibd
-
12:58
positioning of biologics and new therapeutics for crohn's disease
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
17:23
evolving approaches to ibd management: from step-care to treat-to-target
-
21:36
keynote: evolution of disease management in ibd
-
29:46
case discussion: when and how to modify ibd therapies
-
21:04
positioning of biologics in the clinic
-
21:30
ibd: beyond combination therapy
-
12:13
positioning of biologics and new therapeutics for ulcerative colitis
-
18:03
understanding the contraindications to the use of immunomodulators and biologics for ibd
-
31:51
a personalized approach to choosing therapies in ibd: can we do this smarter?
-
21:12
positioning immunomodulators as monotherapies or in combination with biologics